Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB.

Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.

PMID:
25064009
[PubMed - in process]
2.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

PMID:
24711047
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-month, Randomized, Double-blind, Placebo-controlled Study.

Thrasher J, Daniels K, Patel S, Whetteckey J, Woerle HJ.

Endocr Pract. 2014 May 1;20(5):412-20. doi: 10.4158/EP13365.OR.

PMID:
24326003
[PubMed - in process]
4.

Black/African American patients with type 2 diabetes mellitus: study design and baseline patient characteristics from a randomized clinical trial of linagliptin.

Thrasher J, Daniels K, Patel S, Whetteckey J.

Expert Opin Pharmacother. 2012 Dec;13(17):2443-52. doi: 10.1517/14656566.2012.740459. Epub 2012 Nov 8.

PMID:
23134211
[PubMed - indexed for MEDLINE]
5.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium.

Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.

PMID:
22451204
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Copy number variation in familial Parkinson disease.

Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, Halter C, Doheny KF, Gusella JF, Nichols WC, Myers RH, Foroud T, DeStefano AL; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

PLoS One. 2011;6(8):e20988. doi: 10.1371/journal.pone.0020988. Epub 2011 Aug 2.

PMID:
21829596
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Impulse control disorders in Parkinson disease: a multicenter case--control study.

Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M.

Ann Neurol. 2011 Jun;69(6):986-96. doi: 10.1002/ana.22356. Epub 2011 Mar 17.

PMID:
21416496
[PubMed - indexed for MEDLINE]
8.

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE; Parkinson Study Group DATATOP and PRECEPT investigators.

Mov Disord. 2011 Mar;26(4):608-13. doi: 10.1002/mds.23581. Epub 2011 Feb 1.

PMID:
21287602
[PubMed - indexed for MEDLINE]
9.

Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.

Weintraub D, Sohr M, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE.

Ann Neurol. 2010 Dec;68(6):963-8. doi: 10.1002/ana.22164.

PMID:
21154480
[PubMed - indexed for MEDLINE]
10.

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE.

Arch Neurol. 2010 May;67(5):589-95. doi: 10.1001/archneurol.2010.65.

PMID:
20457959
[PubMed - indexed for MEDLINE]
11.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators.

BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53.

PMID:
20356410
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Genomewide association study for onset age in Parkinson disease.

Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T; PROGENI Investigators, Coordinators and Molecular Genetic Laboratories; GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

BMC Med Genet. 2009 Sep 22;10:98. doi: 10.1186/1471-2350-10-98.

PMID:
19772629
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

PMID:
19636047
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Variation in GIGYF2 is not associated with Parkinson disease.

Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jun 2;72(22):1886-92. doi: 10.1212/01.wnl.0000346517.98982.1b. Epub 2009 Mar 11.

PMID:
19279319
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.

PMID:
18987351
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

Hum Genet. 2009 Jan;124(6):593-605. doi: 10.1007/s00439-008-0582-9. Epub 2008 Nov 6.

PMID:
18985386
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Clinical correlates of depressive symptoms in familial Parkinson's disease.

Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators.

Mov Disord. 2008 Nov 15;23(15):2216-23. doi: 10.1002/mds.22285.

PMID:
18785635
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Fatigue in levodopa-naive subjects with Parkinson disease.

Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S; Parkinson Study Group ELLDOPA Investigators.

Neurology. 2008 Aug 12;71(7):481-5. doi: 10.1212/01.wnl.0000324862.29733.69.

PMID:
18695158
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

NINDS NET-PD Investigators.

Clin Neuropharmacol. 2008 May-Jun;31(3):141-50. doi: 10.1097/WNF.0b013e3181342f32.

PMID:
18520981
[PubMed - indexed for MEDLINE]
20.

Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

Fiala KH, Whetteckey J, Manyam BV.

Parkinsonism Relat Disord. 2003 Aug;9(6):321-7. Review.

PMID:
12853231
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk